Dolby Laboratories (DLB) Expected to Announce Earnings on Tuesday

Dolby Laboratories (NYSE:DLB) will likely be posting its Q4 2025 results after the market closes on Tuesday, November 18th. Analysts expect Dolby Laboratories to post earnings of $0.70 per share and revenue of $305.7560 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earningresults page for the latest details on the call scheduled for Tuesday, November 18, 2025 at 5:00 PM ET.

Dolby Laboratories Price Performance

DLB stock opened at $65.58 on Friday. The company has a market capitalization of $6.29 billion, a P/E ratio of 24.02 and a beta of 0.97. Dolby Laboratories has a 12 month low of $64.38 and a 12 month high of $89.66. The firm’s fifty day simple moving average is $69.24 and its 200-day simple moving average is $72.69.

Analyst Upgrades and Downgrades

DLB has been the topic of several analyst reports. Rosenblatt Securities reaffirmed a “buy” rating and set a $95.00 price target on shares of Dolby Laboratories in a research report on Friday, August 1st. Tigress Financial upped their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, August 30th. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $95.75.

Insider Buying and Selling

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total value of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $7,901,110.75. The trade was a 17.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 57,000 shares of company stock worth $4,037,690 over the last three months. Insiders own 38.39% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of the company. iSAM Funds UK Ltd acquired a new position in Dolby Laboratories during the 3rd quarter worth $68,000. US Bancorp DE grew its stake in shares of Dolby Laboratories by 31.3% in the 3rd quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after buying an additional 341 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Dolby Laboratories by 273.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares during the last quarter. Osaic Holdings Inc. increased its stake in shares of Dolby Laboratories by 165.8% in the second quarter. Osaic Holdings Inc. now owns 2,541 shares of the electronics maker’s stock worth $195,000 after purchasing an additional 1,585 shares during the period. Finally, Fiduciary Trust Co bought a new stake in Dolby Laboratories in the 3rd quarter valued at $201,000. 58.56% of the stock is owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.